武汉敬康恩生物医药科技有限公司 公司信息
公司名称:
武汉敬康恩生物医药科技有限公司
电话:
13720134139 086-15871494362
电子邮件:
orders@jknbiochem.com
国籍:
中国
网址:
https://www.jknbiochem.com
产品总数:
6762
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
公司提供产品列表
Infliximab
170277-31-3
Keliximab
174722-30-6
Research Grade Bivatuzumab
Conatumumab
896731-82-1
Erlizumab
211323-03-4
Iratumumab
640735-09-7
Ostarine
841205-47-8
Zanolimumab
652153-01-0
Citatuzumab Bogatox
945228-49-9
Farletuzuma
896723-44-7
Research Grade Sibrotuzumab
Tuvirumab
138660-97-6
Tanezumab
880266-57-9
RAD-140
1182367-47-0
Acadesine
阿卡地新
2627-69-2
Racotumomab
946832-34-4
Libivirumab
569658-79-3
Research Grade Anatumomab
Bapineuzumab
648895-38-9
Zalutumumab
667901-13-5
Galiximab
357613-77-5
Raxibacumab
565451-13-0
ocrelizumab
637334-45-3
Canakinumab
914613-48-2
Tucotuzumab Celmoleukin
339986-90-2
Vapaliximab
336801-86-6
Research Grade Taplitumomab
Regavirumab
153101-26-9
GW501516
317318-70-0
Efungumab
762260-74-2
Belimumab
356547-88-1
Ecromeximab
292819-64-8
SU5408
15966-93-5
Research Grade Golimumab
476181-74-5
Briakinumab
339308-60-0
reslizumab
241473-69-8
Ganitumab
905703-97-1
Anrukinzumab
910649-32-0
Oportuzumab Monatox
945228-48-8
Figitumumab
943453-46-1
Stamulumab
705287-60-1
Research Grade Clenoliximab
182912-58-9
Catumaxomab
509077-98-9
Tremelimumab
745013-59-6
Elsilimomab
468715-71-1
Bertilimumab
375348-49-5
MK-677
伊布莫仑甲磺酸盐
159752-10-0
SR9009
1379686-30-2
YK11
431579-34-9
Tenatumomab
1412891-40-7
Urtoxazumab
502496-16-4
Cixutumumab
947687-12-9
Research Grade J695
Pagibaximab
595566-61-3
Tefibazumab
521079-87-8
Teneliximab
395639-53-9
Metelimumab
272780-74-2
Dacetuzumab
880486-59-9
LGD-3303
LGD3303
917891-35-1
Yttrium (90Y) Tacatuzumab Tetraxetan
476413-07-7
Ertumaxomab
509077-99-0
Mapatumumab
658052-09-6
Volociximab
558480-40-3
Ustekinumab
815610-63-0
Besilesomab
537694-98-7
Pritumumab
499212-74-7
Research Grade Priliximab
147191-91-1
Maribavir
马利巴韦
176161-24-3
Tralokinumab
1044515-88-9
Alacizumab
934216-54-3
Ibalizumab
680188-33-4
Robatumumab
934235-44-6
Nebacumab
138661-01-5
Ipilimumab
477202-00-9
Research Grade Camidanlumab
921618-45-3
Otelixizumab
881191-44-2
Elotuzumab
915296-00-3
Panitumumab
339177-26-3
Research Grade Pintumomab
Lexatumumab
845816-02-6
Obinutuzumab
949142-50-1
Cetuximab
205923-56-4
Andarine
401900-40-1
Research Grade Lerdelimumab
285985-06-0
Denosumab
615258-40-7
Lemalesomab
250242-54-7
Adecatumumab
503605-66-1
Lumiliximab
357613-86-6
Research Grade Otilimab
1638332-55-4
Gantenerumab
1043556-46-2
Exbivirumab
569658-80-6
ofatumumab
679818-59-8
Etaracizumab
892553-42-3
notuzumab
635715-01-4
Epitumomab
372075-37-1
LGD4033
1165910-22-4
Fresolimumab
948564-73-6
Research Grade HuCC49
823788-82-5
Tigatuzumab
918127-53-4
Panobacumab
885053-97-4
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
Copyright 2007© ChemicalBook. All rights reserved.